CervoMed Inc. Deferred Tax Assets, Valuation Allowance
CervoMed Inc. (CRVO) had Deferred Tax Assets, Valuation Allowance of $24.47 million as of 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-24
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $24.47M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $20.73M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $14.91M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $12.05M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $24.47M 10-K · filed 2023-03-24 | |
| 2021-12-31 | $20.73M 10-K · filed 2023-03-24 | |
| 2020-12-31 | $14.91M 10-K · filed 2022-03-18 | |
| 2019-12-31 | $12.05M 10-K · filed 2021-03-17 | |
| 2018-12-31 | $18.09M 10-K · filed 2020-03-17 | |
| 2017-12-31 | $15.24M 10-K · filed 2019-03-19 | $15.24M 10-K · filed 2018-04-02 |
| 2016-12-31 | $16.18M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 | $32.10M 10-K · filed 2016-03-25 |
| 2014-12-31 | $29.14M 10-K · filed 2016-03-25 | |
| 2013-12-31 | $26.27M 10-K · filed 2015-04-03 | -$26.27M 10-K/A · filed 2014-04-23 |
| 2012-12-31 | -$19.23M 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |